Mohamed S. Abou Donia

Molecular Biology

Former affiliations

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Mohamed S. Abou Donia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

Investigating the Impact of the Human Gut Microbiome on the Metabolism of Oral Chemotherapeutic Drugs
Abou Donia, M. S.
NJ Commission on Cancer Research
1/1/18 → 12/31/19
Project: Research project
Uncultivated Bacterial Symbionts of Humans: An Untapped Resource for Drug Discovery
Abou Donia, M. S.
NIH NIAID
9/30/15 → 6/30/20
Project: Research project

3132 Citations
23 h-Index
30 Article
5 Review article
2 Chapter
2 Comment/debate
More
- 2 Short survey
- 1 Innovation

A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont
Liou, C. S., Sirk, S. J., Diaz, C. A. C., Klein, A. P., Fischer, C. R., Higginbottom, S. K., Erez, A., Donia, M. S., Sonnenburg, J. L. & Sattely, E. S., Feb 20 2020, In: Cell. 180, 4, p. 717-728.e19
Research output: Contribution to journal › Article › peer-review
19 Scopus citations
Correction to: Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome (Metabolomics, (2020), 16, 8, (86), 10.1007/s11306-020-01704-z)
Farag, M. A., Hegazi, N. M. & Donia, M. S., Sep 1 2020, In: Metabolomics. 16, 9, 92.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lantibiotics
Kloosterman, A. M., Cimermancic, P., Elsayed, S. S., Du, C., Hadjithomas, M., Donia, M. S., Fischbach, M. A., van Wezel, G. P. & Medema, M. H., Dec 22 2020, In: PLoS biology. 18, 12 December, e3001026.
Research output: Contribution to journal › Article › peer-review

Open Access
Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome
Farag, M. A., Hegazi, N. M. & Donia, M. S., Aug 1 2020, In: Metabolomics. 16, 8, 86.
Research output: Contribution to journal › Article › peer-review
Novel Small Molecule Agent for the Dispersal of Pseudomonas Aeruginosa, and other Type IV Pili Bacteria
Gitai, Z., Scheffler, R., Donia, M. & Sugimoto, Y., Nov 4 2020
Research output: Innovation

Investigating the Impact of the Human Gut Microbiome on the Metabolism of Oral Chemotherapeutic Drugs

Uncultivated Bacterial Symbionts of Humans: An Untapped Resource for Drug Discovery

A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont

Correction to: Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome (Metabolomics, (2020), 16, 8, (86), 10.1007/s11306-020-01704-z)

Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lantibiotics

Molecular networking based LC/MS reveals novel biotransformation products of green coffee by ex vivo cultures of the human gut microbiome

Novel Small Molecule Agent for the Dispersal of Pseudomonas Aeruginosa, and other Type IV Pili Bacteria